In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Whenever your country is hosting a tournament, there is more pressure on you to make your team wi
Record Rs 12.11 trillion transactions from UPI in the festive month of October, see details
UPI Transactions: The Unified Payments Interface (UPI) platform processed 7.3 billion transaction
The Supreme Court on Tuesday strongly objected to the notification of the West Bengal government
Big blow to Bengal government, Calcutta High Court orders CBI inquiry on post-poll violence
Kolkata: The West Bengal government has suffered a major setback. The Calcutta High Court has ord
Delhi Chief Minister Arvind Kejriwal may consider the excise policy scam as a fraud, but the way
Black Fungus In Gurugram 14 new black fungus patients found in 24 hours
Gurugram. The effect of corona infection has lessened now, but black fungus infection (mucormycos
These three states failing to deal with Corona, the teams sent from the center reported the flaws
The second wave of the Coronavirus has seen the situation worsening throughout the country. Every
The Indian team has created history by securing the top spot in the latest Test team rankings rel
Violence continues against the Waqf Amendment Act in Murshidabad district of West Bengal. The sce
The level of pollution in the country's capital Delhi is continuously increasing. Delhi Environme
